Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome
SPTBN1 encodes βII-spectrin, the ubiquitously expressed β-spectrin that forms micrometer-scale networks associated with plasma membranes. Mice deficient in neuronal βII-spectrin have defects in cortical organization, developmental delay and behavioral deficiencies. These phenotypes, while less sever...
Saved in:
Published in: | Nature genetics Vol. 53; no. 7; pp. 1006 - 1021 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
New York
Nature Publishing Group US
01-07-2021
Nature Publishing Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | SPTBN1
encodes βII-spectrin, the ubiquitously expressed β-spectrin that forms micrometer-scale networks associated with plasma membranes. Mice deficient in neuronal βII-spectrin have defects in cortical organization, developmental delay and behavioral deficiencies. These phenotypes, while less severe, are observed in haploinsufficient animals, suggesting that individuals carrying heterozygous
SPTBN1
variants may also show measurable compromise of neural development and function. Here we identify heterozygous
SPTBN1
variants in 29 individuals with developmental, language and motor delays; mild to severe intellectual disability; autistic features; seizures; behavioral and movement abnormalities; hypotonia; and variable dysmorphic facial features. We show that these
SPTBN1
variants lead to effects that affect βII-spectrin stability, disrupt binding to key molecular partners, and disturb cytoskeleton organization and dynamics. Our studies define
SPTBN1
variants as the genetic basis of a neurodevelopmental syndrome, expand the set of spectrinopathies affecting the brain and underscore the critical role of βII-spectrin in the central nervous system.
SPTBN1 mutations cause a neurodevelopmental syndrome characterized by intellectual disability, language and motor delays, autism, seizures and other features. The variants disrupt βII-spectrin function and disturb cytoskeletal organization and dynamics. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Consortia Undiagnosed Diseases Network M.A.C. and D.N.L. conceived and planned the study with input from Q.K.-G.T and R.C.S. M.A.C. managed the collection, analysis, and interpretation of patient clinical data with Q.K.-G.T., R.C.S., and D.N.L. D.N.L. designed the cell biology, histology, and biochemistry studies, performed these and analyzed the data together with B.A.C., K.A.B., S.D., D.A., R.J.E., S.A., J.C.B., and L.F.R. A.A.B., L.J.M., and A.S.B. generated and characterized the iPSCs. S.T., M.T.Z., B.T. and D.N.L. performed the structural modeling. K.M.H. and S.S.M. performed the mouse behavioral studies. M.C.S. contributed reagents. M.A.C. and D.N.L. wrote the manuscript with contributions from B.A.C., R.C.S., S.S.M., M.T.Z., and B.T. E.W.K. and D.N.L. supervised the study. All other authors including Q.K.-G.T. and R.C.S. contributed clinical data. All authors approved the final manuscript. Rebecca C. Spillmann4, Allyn McConkie-Rosell4, Brendan C. Lanpher1,39, and Queenie K.-G. Tan4 A full list of consortium members appears in the Supplementary Note. Genomics England Research Consortium Author Contributions Damian Smedley27 |
ISSN: | 1061-4036 1546-1718 1546-1718 |
DOI: | 10.1038/s41588-021-00886-z |